3B63ICD-11 MMS 2026-01
Thrombocytosis
Description
A disease caused by essential thrombocytosis or other myelo-proliferative disorders such as chronic myelogenous leukaemia, polycythaemia, myelofibrosis. This disease can also have secondary causes such as inflammation, surgery, hyposplenism, splenectomy, asplenia, iron deficiency anaemia or haemorrhage. This disease is characterised by elevated platelet count in the blood. Confirmation is by identification of increased platelet count in a blood sample.
Exclusions from above levels
JA43.3– Postpartum coagulation defects04– Diseases of the immune system05– Endocrine, nutritional or metabolic diseases
Show allHide
18– Complications of pregnancy, childbirth or the puerperium19– Certain conditions originating in the perinatal period20– Congenital malformations, deformations or chromosomal abnormalities22– Injury, poisoning or certain other consequences of external causes- http://id.who.int/icd/entity/1000704511 – Human immunodeficiency virus disease
JB64.1– Other diseases of the blood or blood-forming organs or certain disorders involving the immune mechanism complicating pregnancy, childbirth or the puerperium
Child codes
Sibling codes
3B60– Non-thrombocytopenic purpura3B61– Thrombophilia3B62– Qualitative platelet defects3B64– Thrombocytopenia3B65– Thrombotic microangiopathy, not elsewhere classified3B6Y– Other specified coagulation defects, purpura or other haemorrhagic or related conditions3B6Z– Coagulation defects, purpura or other haemorrhagic or related conditions, unspecified
Foundation entity
Part of: 03: Diseases of the blood or blood-forming organs